Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer.
Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer.
Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer.
Adriacell is a biotechnology company focused on the research and development of new generation biopharmaceuticals for the diagnosis and treatment of cancer.
CROMOC
Adriacell's CROMOC represents a new class of cancer therapeutics. CROMOC molecules are DNA-double strand breaking biomolecules that actively penetrate cell walls and introduce DNA double strand breaks through an integrated endonuclease in tumor specific loosely packed chromatin.
CROMOC molecules distribute equally well in the body but do not cross the blood brain barrier. They do not enter into the mitochondria.
ADRIACELL NEWS
Adriacell S.p.A.
Adriacell S.p.A. - Trieste (Italy)
Tel: +39 0403757771
Fax: +39 0403757773
Adriacell S.p.A. - Martinsried (Germany)
Tel.: +49 (0) 8970076491